WhatsApp
Journal of Oncology Research and Therapy
ISSN: 2574-710X
Impact Factor: 4.327

research article

A Phase II Study of Capecitabine and Oxaliplatin in the Treatment of Patients with Advanced HER-2 Negative Breast Cancer

A Phase II Study of Capecitabine and Oxaliplatin in the Treatment of Patients with Advanced HER-2 Negative Breast Cancer

Charlotte Margareta Brinch*, Sidsel Christy Lindgaard, Dorte Carlsen, Peter Grundtvig Soerensen, Dorte L. Nielsen

Journal of Oncology Research and Therapy
Update cookies preferences